Back to Market返回行情
20
200230.KQ TELCON RF PHARMACEUTICAL. Inc.
KOETechnology₩360-0.28%LiveMarket Cap: ₩5.35B
As of 2026-06-05 07:52
Valuation
P/E (TTM)
-2.97
PEG
—
P/B
0.25
P/S
0.12
EV/EBITDA
2.70
DCF Value
—
FCF Yield
7.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
16.2%
Operating Margin
1.9%
Net Margin
-19.4%
ROE
-8.9%
ROA
-5.5%
ROIC
0.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | ₩9.70B | 10.5% | ₩-1.42B | ₩-11.47B | ₩-167.37 | — |
| Q4 2025 | ₩13.32B | 12.0% | ₩2.63B | ₩9.85B | ₩143.78 | — |
| Q3 2025 | ₩9.82B | 24.3% | ₩-8.7M | ₩-4.88B | ₩-138.00 | — |
| Q2 2025 | ₩10.03B | 19.1% | ₩-396.8M | ₩-1.80B | ₩-149.65 | — |
| Q1 2025 | ₩9.98B | 14.1% | ₩-1.50B | ₩-14.62B | ₩-1,216.18 | — |
| Q4 2024 | ₩13.84B | 43.4% | ₩3.13B | ₩-12.20B | ₩-1,010.10 | — |
| Q3 2024 | ₩7.16B | 11.9% | ₩-1.24B | ₩3.02B | ₩67.40 | — |
| Q2 2024 | ₩8.83B | 14.7% | ₩-1.00B | ₩-9.87B | ₩-159.18 | — |
| Q1 2024 | ₩8.04B | 8.0% | ₩-965.2M | ₩-7.27B | ₩-117.37 | — |
| Q4 2023 | ₩12.93B | 31.6% | ₩2.50B | ₩4.07B | ₩65.73 | — |
| Q3 2023 | ₩8.85B | 14.8% | ₩-192.6M | ₩-10.12B | ₩-90.45 | — |
| Q2 2023 | ₩7.38B | 8.3% | ₩-510.2M | ₩-27.42B | ₩-246.78 | — |